Celecoxib prevents malignant progression of smoking-induced lung tumors via suppression of the COX-2/PGE2 signaling pathway in mice

IntroductionLung cancer is characterized by a poor prognosis and is a significant comorbidity of chronic obstructive pulmonary disease (COPD). Therefore, effective chemopreventive agents are warranted. We evaluated the effects of the cyclooxygenase-2 (COX-2) inhibitor celecoxib on the prevention of...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Kaori Sakurai, Shotaro Chubachi, Jun Miyata, Junko Hamamoto, Tatsuro Naganuma, Takashi Shimada, Shiro Otake, Shingo Nakayama, Hidehiro Irie, Akihiro Tsutsumi, Naofumi Kameyama, Ahmed E. Hegab, Masayuki Shimoda, Hideki Terai, Hiroyuki Yasuda, Yae Kanai, Makoto Arita, Koichi Fukunaga
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2025-03-01
Reeks:	Frontiers in Immunology
Onderwerpen:	chronic obstructive pulmonary disease lung neoplasms cyclooxygenase 2 inhibitor smoking prostaglandin E2 chemoprevention
Online toegang:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1557790/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!